Here we go again…
Hiyo vitu nilimeza, nikanywa pombe, nikazisahau but thank God I escaped unhurt. Unahara vishenzi.
Help us Lord
VILE HAKUNA MBICHA, PEP GURDIOLA AMEDO ?
Ama Ni shares za Pepsi co.
Upuus…
Ama ni pep talk?
anko tulia uone Kaimosi University ikua kubwa kuliko UON
Ango kuliendaje
upussy!
28 days of pure unadulterated hell.
pole
Guys have started using this stuff like p2. @Luther12 is there a possibility of this stuff losing its efficiency with multiple use by an individual or over a cluster in a population?
[SIZE=1]“efficacy” [/SIZE]
Weka hekaya maragoli
my fear exactly
I really had a debate in my head between which word to use. Had gone with efficacy first, but i havent had my morning coffee so my mind told me otherwise.
Speaking of coffee, want some?
already having some coffee rn … send toast
Plausible. Partly the reason why PEP guidelines have evolved to use full HAART: to minimize chances of viral resistance/mutation.
Pole. That’s mostly commonly seen with Lopinavir/ritonavir, so called Kaletra. The one in current use, Atazanavir/ritonavir doesn’t have diarrhea as a common side effect, just transient cosmetic jaundice.
English please